Cargando…
Inhaled Dry Powder Antibiotics in Patients with Non-Cystic Fibrosis Bronchiectasis: Efficacy and Safety in a Real-Life Study
Background: Nebulised antibiotics are habitually used in patients with bronchiectasis, but the use of dry powder inhaled antibiotics (DPIA) in these patients is extremely limited. This study seeks to analyse the efficacy and safety of DPIA in bronchiectasis patients. Material and methods: Multi-cent...
Autores principales: | Martínez-García, Miguel Ángel, Oscullo, Grace, Barreiro, Esther, Cuenca, Selene, Cervera, Angela, Padilla-Galo, Alicia, de la Rosa, David, Navarro, Annie, Giron, Rosa, Carbonero, Francisco, Castro Otero, Maria, Casas, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408283/ https://www.ncbi.nlm.nih.gov/pubmed/32708262 http://dx.doi.org/10.3390/jcm9072317 |
Ejemplares similares
-
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
por: Wilson, Robert, et al.
Publicado: (2013) -
Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review
por: Martínez-García, Miguel Ángel, et al.
Publicado: (2022) -
Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients
por: Hoppentocht, Marcel, et al.
Publicado: (2016) -
Towards a new definition of non-cystic fibrosis bronchiectasis
por: Martinez-Garcia, Miguel Ángel, et al.
Publicado: (2022) -
Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)